Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, Gazit R, Gonen-Gross T, Hanna J, Nahari E, Porgador A, Honigman A, Plachter B, Mevorach D, Wolf DG, Mandelboim O.

Nat Immunol. 2005 May;6(5):515-23. Epub 2005 Apr 10.

PMID:
15821739
2.

Viral evasion of NK-cell activation.

Rajagopalan S, Long EO.

Trends Immunol. 2005 Aug;26(8):403-5.

PMID:
15979408
3.

Evidence that the cellular ligand for the human NK cell activation receptor NKp30 is not a heparan sulfate glycosaminoglycan.

Warren HS, Jones AL, Freeman C, Bettadapura J, Parish CR.

J Immunol. 2005 Jul 1;175(1):207-12.

4.

NKp30-dependent cytolysis of filovirus-infected human dendritic cells.

Fuller CL, Ruthel G, Warfield KL, Swenson DL, Bosio CM, Aman MJ, Bavari S.

Cell Microbiol. 2007 Apr;9(4):962-76.

PMID:
17381429
5.

Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44.

Byrd A, Hoffmann SC, Jarahian M, Momburg F, Watzl C.

PLoS One. 2007 Dec 19;2(12):e1339.

6.

Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors.

Poggi A, Prevosto C, Massaro AM, Negrini S, Urbani S, Pierri I, Saccardi R, Gobbi M, Zocchi MR.

J Immunol. 2005 Nov 15;175(10):6352-60.

7.

NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.

Poggi A, Prevosto C, Zancolli M, Canevali P, Musso A, Zocchi MR.

Ann N Y Acad Sci. 2007 Aug;1109:47-57.

PMID:
17785290
8.
9.

The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function.

Della Chiesa M, Carlomagno S, Frumento G, Balsamo M, Cantoni C, Conte R, Moretta L, Moretta A, Vitale M.

Blood. 2006 Dec 15;108(13):4118-25. Epub 2006 Aug 10.

10.

Histone deacetylase inhibitors suppress natural killer cell cytolytic activity.

Ogbomo H, Michaelis M, Kreuter J, Doerr HW, Cinatl J Jr.

FEBS Lett. 2007 Apr 3;581(7):1317-22. Epub 2007 Mar 1.

11.

Natural cytotoxicity receptors: pattern recognition and involvement of carbohydrates.

Porgador A.

ScientificWorldJournal. 2005 Feb 23;5:151-4. Review.

12.

Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium.

Vankayalapati R, Garg A, Porgador A, Griffith DE, Klucar P, Safi H, Girard WM, Cosman D, Spies T, Barnes PF.

J Immunol. 2005 Oct 1;175(7):4611-7.

13.

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.

Pogge von Strandmann E, Simhadri VR, von Tresckow B, Sasse S, Reiners KS, Hansen HP, Rothe A, Böll B, Simhadri VL, Borchmann P, McKinnon PJ, Hallek M, Engert A.

Immunity. 2007 Dec;27(6):965-74. Epub 2007 Dec 6.

14.

Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

Fauriat C, Just-Landi S, Mallet F, Arnoulet C, Sainty D, Olive D, Costello RT.

Blood. 2007 Jan 1;109(1):323-30. Epub 2006 Aug 29.

15.

Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages.

Chevillotte M, Landwehr S, Linta L, Frascaroli G, Lüske A, Buser C, Mertens T, von Einem J.

J Virol. 2009 Mar;83(6):2480-90. doi: 10.1128/JVI.01818-08. Epub 2008 Dec 30.

16.

Critical and differential roles of NKp46- and NKp30-activating receptors expressed by uterine NK cells in early pregnancy.

El Costa H, Casemayou A, Aguerre-Girr M, Rabot M, Berrebi A, Parant O, Clouet-Delannoy M, Lombardelli L, Jabrane-Ferrat N, Rukavina D, Bensussan A, Piccinni MP, Le Bouteiller P, Tabiasco J.

J Immunol. 2008 Sep 1;181(5):3009-17.

17.

Differential NKp30 inducibility in chimpanzee NK cells and conserved NK cell phenotype and function in long-term HIV-1-infected animals.

Rutjens E, Mazza S, Biassoni R, Koopman G, Radic L, Fogli M, Costa P, Mingari MC, Moretta L, Heeney J, De Maria A.

J Immunol. 2007 Feb 1;178(3):1702-12. Erratum in: J Immunol. 2007 Jul 15;179(2):1389.

18.

Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142.

Chalupny NJ, Rein-Weston A, Dosch S, Cosman D.

Biochem Biophys Res Commun. 2006 Jul 21;346(1):175-81. Epub 2006 May 24.

PMID:
16750166
20.

TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.

Hart OM, Athie-Morales V, O'Connor GM, Gardiner CM.

J Immunol. 2005 Aug 1;175(3):1636-42.

Supplemental Content

Support Center